| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S1474-4422(19)30354-0 |
| P698 | PubMed publication ID | 31701893 |
| P50 | author | James B. Rowe | Q24265625 |
| Daniela Galimberti | Q32425219 | ||
| Lieke H Meeter | Q59568565 | ||
| Markus Otto | Q67390357 | ||
| Stefano Cappa | Q82852861 | ||
| Fermin Moreno | Q88264745 | ||
| Mario Masellis | Q88866629 | ||
| Katrina Moore | Q89553471 | ||
| Janne M Papma | Q90067027 | ||
| Inge Mw Verberk | Q90972977 | ||
| Lize C Jiskoot | Q91785705 | ||
| Maria Carmela Tartaglia | Q91863644 | ||
| Yolande A L Pijnenburg | Q97517231 | ||
| Frank Jan de Jong | Q117242424 | ||
| Caroline Graff | Q37374962 | ||
| Giovanni B. Frisoni | Q37836517 | ||
| David M. Cash | Q41198429 | ||
| Jonathan D Rohrer | Q42407224 | ||
| Rik Vandenberghe | Q42680603 | ||
| John Van Swieten | Q42684069 | ||
| Elizabeth Finger | Q42734328 | ||
| Johannes Levin | Q42757617 | ||
| Robert Laforce | Q55723917 | ||
| Raquel Sanchez-Valle | Q56697466 | ||
| Charlotte Teunissen | Q56887227 | ||
| P2093 | author name string | Matthis Synofzik | |
| Fabrizio Tagliavini | |||
| Elise G P Dopper | |||
| Simon Ducharme | |||
| Dimitris Rizopoulos | |||
| Barbara Borroni | |||
| Martina Bocchetta | |||
| Alexandre de Mendonça | |||
| Adrian Danek | |||
| Isabel Santana | |||
| Carolin Heller | |||
| Chris Butler | |||
| Alex Gerhard | |||
| Mollie Neason | |||
| Rhian S Convery | |||
| Jessica L Panman | |||
| Emma L van der Ende | |||
| Jackie M Poos | |||
| Genetic Frontotemporal dementia Initiative (GENFI) | |||
| P2860 | cites work | Classification of primary progressive aphasia and its variants | Q24594803 |
| Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia | Q24598142 | ||
| El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis | Q29619074 | ||
| Cerebrospinal fluid neurofilament concentration reflects disease severity in frontotemporal degeneration | Q33610029 | ||
| White matter hyperintensities are seen only in GRN mutation carriers in the GENFI cohort | Q33676267 | ||
| Accurate automatic estimation of total intracranial volume: a nuisance variable with less nuisance | Q34698353 | ||
| Neurofilament light chain: A prognostic biomarker in amyotrophic lateral sclerosis. | Q35686186 | ||
| Neurofilament light chain: a biomarker for genetic frontotemporal dementia | Q37208495 | ||
| Mutations in progranulin (GRN) within the spectrum of clinical and pathological phenotypes of frontotemporal dementia | Q37260852 | ||
| Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia | Q37304614 | ||
| Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease | Q60961744 | ||
| Neurofilament Light Chain as a Biomarker in Multiple Sclerosis | Q64071842 | ||
| Longitudinal measurement of serum neurofilament light in presymptomatic familial Alzheimer's disease | Q64264603 | ||
| Cerebrospinal fluid and serum antibodies against neurofilaments in patients with amyotrophic lateral sclerosis | Q84997443 | ||
| Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease | Q90139959 | ||
| Neurofilament light: A candidate biomarker of presymptomatic amyotrophic lateral sclerosis and phenoconversion | Q90266760 | ||
| Neurofilament as a blood marker for diagnosis and monitoring of primary progressive aphasias | Q38381072 | ||
| Review: an update on clinical, genetic and pathological aspects of frontotemporal lobar degenerations. | Q38514971 | ||
| Imaging and fluid biomarkers in frontotemporal dementia. | Q38670219 | ||
| Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa | Q38882174 | ||
| Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative (GENFI) study: a cross-sectional analysis. | Q39041947 | ||
| Distinct genetic forms of frontotemporal dementia. | Q40059334 | ||
| Geodesic Information Flows: Spatially-Variant Graphs and Their Application to Segmentation and Fusion | Q41064897 | ||
| Immune reactivity to neurofilament proteins in the clinical staging of amyotrophic lateral sclerosis | Q43718510 | ||
| Progranulin: a new avenue towards the understanding and treatment of neurodegenerative disease | Q47623958 | ||
| Neurofilament Light Chain in Blood and CSF as Marker of Disease Progression in Mouse Models and in Neurodegenerative Diseases | Q48682038 | ||
| Interactive algorithms for the segmentation and quantitation of 3-D MRI brain scans. | Q48722974 | ||
| Diagnostic value of cerebrospinal fluid tau, neurofilament, and progranulin in definite frontotemporal lobar degeneration. | Q52646410 | ||
| Serum neurofilament light chain in behavioral variant frontotemporal dementia | Q57158113 | ||
| Neurofilament light chain in serum for the diagnosis of amyotrophic lateral sclerosis | Q57476263 | ||
| Neurofilaments as biomarkers in neurological disorders | Q57588817 | ||
| P433 | issue | 12 | |
| P921 | main subject | frontotemporal dementia | Q18592 |
| P304 | page(s) | 1103-1111 | |
| P577 | publication date | 2019-12-01 | |
| P1433 | published in | Lancet Neurology | Q15755067 |
| P1476 | title | Serum neurofilament light chain in genetic frontotemporal dementia: a longitudinal, multicentre cohort study | |
| P478 | volume | 18 |
| Q102388772 | Longitudinal analysis of premotor anthropometric and serological markers of Parkinson's disease |
| Q92124440 | Neurofilaments in blood is a new promising preclinical biomarker for the screening of natural scrapie in sheep |
| Q90167116 | Neurofilaments in disease: what do we know? |
| Q91183303 | Serum neurofilament light chain as a preclinical marker of neurodegeneration |
Search more.